Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice

Po Kuan Chao, Hsiao Fu Chang, Li Chin Ou, Jian Ying Chuang, Pin Tse Lee, Wan Ting Chang, Shu Chun Chen, Shau Hua Ueng, John Tsu An Hsu, Pao Luh Tao, Ping-Yee Law, Horace H Loh, Shiu Hwa Yeh

Research output: Contribution to journalArticle

Abstract

Morphine is a unique opioid analgesic that activates the mu-opioid receptor (MOR) without efficiently promoting its endocytosis that may underlie side effects. Our objective was to discover a novel enhancer of ligand-induced MOR endocytosis and determine its effects on analgesia, tolerance and dependence. We used high-throughput screening to identify convallatoxin as an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Treatment of cells with convallatoxin enhanced morphine-induced MOR endocytosis through an adaptor protein 2 (AP2)/clathrin-dependent mechanism, attenuated morphine-induced phosphorylation of MOR, and diminished desensitization of membrane hyperpolarization. Furthermore, co-treatment with chronic convallatoxin reduced morphine tolerance in animal models of acute thermal pain and chronic inflammatory pain. Acute convallatoxin administration reversed morphine tolerance and dependence in morphine-tolerant mice. These findings suggest convallatoxin are potentially therapeutic for morphine side effects and open a new avenue to study MOR trafficking.

Original languageEnglish (US)
Article number2405
JournalScientific reports
Volume9
Issue number1
DOIs
StatePublished - Dec 1 2019

Fingerprint

mu Opioid Receptor
Endocytosis
Morphine
Ligands
Morphine Dependence
Clathrin
Acute Pain
Chronic Pain
Analgesia
Opioid Analgesics
convallatoxin
Therapeutics
Animal Models
Hot Temperature
Phosphorylation
Membranes
Proteins

PubMed: MeSH publication types

  • Journal Article

Cite this

Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice. / Chao, Po Kuan; Chang, Hsiao Fu; Ou, Li Chin; Chuang, Jian Ying; Lee, Pin Tse; Chang, Wan Ting; Chen, Shu Chun; Ueng, Shau Hua; Hsu, John Tsu An; Tao, Pao Luh; Law, Ping-Yee; Loh, Horace H; Yeh, Shiu Hwa.

In: Scientific reports, Vol. 9, No. 1, 2405, 01.12.2019.

Research output: Contribution to journalArticle

Chao, PK, Chang, HF, Ou, LC, Chuang, JY, Lee, PT, Chang, WT, Chen, SC, Ueng, SH, Hsu, JTA, Tao, PL, Law, P-Y, Loh, HH & Yeh, SH 2019, 'Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice', Scientific reports, vol. 9, no. 1, 2405. https://doi.org/10.1038/s41598-019-39555-x
Chao, Po Kuan ; Chang, Hsiao Fu ; Ou, Li Chin ; Chuang, Jian Ying ; Lee, Pin Tse ; Chang, Wan Ting ; Chen, Shu Chun ; Ueng, Shau Hua ; Hsu, John Tsu An ; Tao, Pao Luh ; Law, Ping-Yee ; Loh, Horace H ; Yeh, Shiu Hwa. / Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice. In: Scientific reports. 2019 ; Vol. 9, No. 1.
@article{b2ab172fe3554515815dabc2270268d3,
title = "Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice",
abstract = "Morphine is a unique opioid analgesic that activates the mu-opioid receptor (MOR) without efficiently promoting its endocytosis that may underlie side effects. Our objective was to discover a novel enhancer of ligand-induced MOR endocytosis and determine its effects on analgesia, tolerance and dependence. We used high-throughput screening to identify convallatoxin as an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Treatment of cells with convallatoxin enhanced morphine-induced MOR endocytosis through an adaptor protein 2 (AP2)/clathrin-dependent mechanism, attenuated morphine-induced phosphorylation of MOR, and diminished desensitization of membrane hyperpolarization. Furthermore, co-treatment with chronic convallatoxin reduced morphine tolerance in animal models of acute thermal pain and chronic inflammatory pain. Acute convallatoxin administration reversed morphine tolerance and dependence in morphine-tolerant mice. These findings suggest convallatoxin are potentially therapeutic for morphine side effects and open a new avenue to study MOR trafficking.",
author = "Chao, {Po Kuan} and Chang, {Hsiao Fu} and Ou, {Li Chin} and Chuang, {Jian Ying} and Lee, {Pin Tse} and Chang, {Wan Ting} and Chen, {Shu Chun} and Ueng, {Shau Hua} and Hsu, {John Tsu An} and Tao, {Pao Luh} and Ping-Yee Law and Loh, {Horace H} and Yeh, {Shiu Hwa}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41598-019-39555-x",
language = "English (US)",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice

AU - Chao, Po Kuan

AU - Chang, Hsiao Fu

AU - Ou, Li Chin

AU - Chuang, Jian Ying

AU - Lee, Pin Tse

AU - Chang, Wan Ting

AU - Chen, Shu Chun

AU - Ueng, Shau Hua

AU - Hsu, John Tsu An

AU - Tao, Pao Luh

AU - Law, Ping-Yee

AU - Loh, Horace H

AU - Yeh, Shiu Hwa

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Morphine is a unique opioid analgesic that activates the mu-opioid receptor (MOR) without efficiently promoting its endocytosis that may underlie side effects. Our objective was to discover a novel enhancer of ligand-induced MOR endocytosis and determine its effects on analgesia, tolerance and dependence. We used high-throughput screening to identify convallatoxin as an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Treatment of cells with convallatoxin enhanced morphine-induced MOR endocytosis through an adaptor protein 2 (AP2)/clathrin-dependent mechanism, attenuated morphine-induced phosphorylation of MOR, and diminished desensitization of membrane hyperpolarization. Furthermore, co-treatment with chronic convallatoxin reduced morphine tolerance in animal models of acute thermal pain and chronic inflammatory pain. Acute convallatoxin administration reversed morphine tolerance and dependence in morphine-tolerant mice. These findings suggest convallatoxin are potentially therapeutic for morphine side effects and open a new avenue to study MOR trafficking.

AB - Morphine is a unique opioid analgesic that activates the mu-opioid receptor (MOR) without efficiently promoting its endocytosis that may underlie side effects. Our objective was to discover a novel enhancer of ligand-induced MOR endocytosis and determine its effects on analgesia, tolerance and dependence. We used high-throughput screening to identify convallatoxin as an enhancer of ligand-induced MOR endocytosis with high potency and efficacy. Treatment of cells with convallatoxin enhanced morphine-induced MOR endocytosis through an adaptor protein 2 (AP2)/clathrin-dependent mechanism, attenuated morphine-induced phosphorylation of MOR, and diminished desensitization of membrane hyperpolarization. Furthermore, co-treatment with chronic convallatoxin reduced morphine tolerance in animal models of acute thermal pain and chronic inflammatory pain. Acute convallatoxin administration reversed morphine tolerance and dependence in morphine-tolerant mice. These findings suggest convallatoxin are potentially therapeutic for morphine side effects and open a new avenue to study MOR trafficking.

UR - http://www.scopus.com/inward/record.url?scp=85061780423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061780423&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-39555-x

DO - 10.1038/s41598-019-39555-x

M3 - Article

C2 - 30787373

AN - SCOPUS:85061780423

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 2405

ER -